SGH Capital US
SGH Capital US is a company.
Financial History
Leadership Team
Key people at SGH Capital US.
SGH Capital US is a company.
Key people at SGH Capital US.
Key people at SGH Capital US.
SGH Capital is a Luxembourg-based venture capital firm founded in 2014, specializing in early- and mid-stage investments in disruptive technology companies across the US, Western Europe, and select regions like India.[1][2][3][5] Its mission centers on fostering innovation by partnering with visionary entrepreneurs, leveraging an extensive global network, industry expertise, and a proprietary AI platform powered by over 7,000 scientists across 91 countries to enable precise capital allocation.[1][2][5] The investment philosophy is stage-agnostic yet data-driven, emphasizing "quantamental" and machine learning approaches to identify high-potential ventures, with a track record of over 200 investments, support for more than 10 unicorns, and facilitation of over 5 IPOs.[2][3] Key sectors include fintech, AI, health tech, blockchain, Web3, enterprise technology, and robotics, deployed through multiple funds like SGH/Alpha (flagship, heavy in Silicon Valley), SGH/One, SGH/Fluid (fintech/blockchain focus), and SGH/Growth (Series B-C).[1][2][5] In the startup ecosystem, SGH Capital impacts growth by providing not just equity and venture debt but also operating support via its operator-first style, helping companies scale toward market leadership and exits.[1][2]
SGH Capital was founded in 2014 by Alexandre Azoulay, a Harvard Business School MBA holder with over 15 years in business development, entrepreneurship, and private equity across the US, Europe, and Middle East.[2][3][5] Azoulay has driven more than 30 deals in technology, healthcare, and consumer goods, emphasizing data-driven strategies and notable exits.[1] Key team members include Karine Arama, with expertise in investment banking, blockchain, and international finance from University Dauphine-PSL.[2][3][5] The firm evolved from a focus on early-stage tech in the US and Europe to a multi-fund structure incorporating AI-driven tools and expanded into fintech, Web3 infrastructure, and growth equity, backed by a global scientist community for advanced prediction models.[2][5] Early traction came through funds like SGH/One (pre-seed to Series B) and SGH/Alpha, establishing a versatile, vertical-agnostic approach with typical checks of €1.5-3 million.[3][5]
SGH Capital rides the wave of AI-augmented venture capital and decentralized tech trends like Web3, blockchain, and fintech infrastructure, deploying capital into US-centric innovation hubs amid Europe's rising tech ecosystem.[1][2][5] Timing aligns with post-2020 surges in AI, crypto recovery, and cross-border tech scaling, where its proprietary platform addresses VC inefficiencies in deal sourcing and prediction—critical as global VC funding hit record dispersion in 2025.[2][5] Market forces favoring it include Silicon Valley's enduring dominance (75% Alpha allocation), Europe's regulatory push for fintech/AI (e.g., via funds in Germany, France), and India's emerging tech boom.[1][3] The firm influences the ecosystem by democratizing access via scientist-backed models, supporting unicorns/IPOs that redefine sectors, and bridging US-Europe gaps to accelerate disruptive growth.[2][3]
SGH Capital is poised to expand its AI-driven edge, potentially scaling funds like SGH/Growth amid maturing Web3 and AI markets, with deeper US penetration and selective emerging-market bets.[2][5] Trends like advanced quantamental VC, regulatory clarity in DeFi, and AI-health intersections will shape its trajectory, amplifying influence through more unicorns and exits as global tech funding rebounds.[1][2] Its evolution from founder-led boutique to tech-powered collective positions it to redefine precision investing, empowering the next wave of market-redefining entrepreneurs.